|
SUPER REFINED®
OLEIC ACID NF
SUPER REFINING technology was developed by Croda to
improve the quality of naturally occurring oils. SUPER
REFINING involves proprietary flash chromatography that
reduces polar impurities normally present in lipids. When
applied to Oleic Acid NF the resulting
SUPER REFINED OLEIC ACID NF is a nearly colorless product
with a low Peroxide Value
Oleic acid is a naturally occurring fatty acid commonly found
in vegetable and animal fats. The raw material source for
SUPER REFINED OLEIC ACID NF is exclusively non-animal
in origin. This is designed to help meet the needs of our
customers and to increase regulatory acceptance of final
formulations.
Oleic acid is an 18 carbon fatty acid with one double bond at
the omega 9 (w-9)
position also referred to as C18:1n-9 and (Z)-9-Octadecenoic
acid. The empirical formula is C18H34O2
the structure is illustrated below.
 |
Oleic acid does not exist alone in nature. Included in oleic
acid products are other naturally occurring fatty acids such
as stearic and palmitic which are saturated. In addition
unsaturated fatty acids such as linoleic are also present.
SUPER REFINED OLEIC ACID NF contains 80 to 88% Oleic Acid
with the other related fatty acids comprising the remaining
balance.
PRODUCT FEATURES
-
Plant derived material, a
Non-animal product.
-
High Oleic Acid content,
minimum 80%
-
Low Peroxide Value
-
Colorless
-
Lot to lot uniformity imparted by the Super
Refining process
PHARMACEUTICAL AND HEALTHCARE USES
-
Emulsifying and solublizing
agent1
-
Defoamer2
-
Absorption enhancer in
topical, transdermal and oral dosages3,4,5,6,7,8,9
-
Component of Self Emulsifying
Drug Delivery Systems (SEDDS)10
-
Nasal and pulmonary MDI (Meter
Dose Inhalers)11
-
Oral and Parenteral Diagnostic
vehicle12,13
-
Raw material for the
production of other pharmaceutical ingredients
PHYSICAL DATA
|
Solubility Profile, 2.5% w/w @25°C |
|
·
Mineral Oil:
|
ST*
(* Soluble clear when
warm) |
|
·
Isopropanol:
|
SC |
|
·
Propylene
Glycol: |
SC |
|
·
Water: |
I |
|
Solubility of Active Pharmaceutical
Ingredients (API), 3% w/w |
|
·
Bacitracin: |
I |
|
·
Diphenhydramine
HCl: |
I |
|
·
Lidocaine: |
SC |
|
·
Ibuprofen: |
SC |
| |
|
|
Hildebrand Solubility Parameter (HSP)
=
8.99
|
| |
|
|
Required HLB =
15.97 |
|
SC=Soluble Clear, ST=Soluble Translucent,
P=Partially Soluble, D=Dispersible, I=Insoluble
TYPICAL ANALYSIS OF SUPER REFINED OLEIC ACID NF
|
Appearance |
Clear Liquid |
|
Color (APHA) |
60 Max. |
|
Peroxide Value mEq/kg) |
5.0 Max. |
REGULATORY STATUS
-
NF Monograph Compliant
-
PhEur (EP) Monograph Compliant
-
FDA Inactive Ingredient Guide
(inhalation and nasal aerosols, tablets, and transdermal
preparations)
-
Listed in 21 CFR 172 Food Additives
Permitted for Direct Addition to Food for Human Consumption
-
TSCA
Listed
COMMERCIAL
INFORMATION
SUPER REFINED OLEIC ACID NF contains 200 ppm BHT, a
food approved antioxidant. The material is packaged in lined
tight-head steel drums with a nitrogen headspace to protect
the product from oxidation. The product is commercially
available in 35 and 400 pound containers.
Samples may be obtained by contacting our Sample Department at
(732) 417-0800, by email at
marketing@crodausa.com, through our website
www.crodausa.com, or your Croda Sales Representative.
REFERENCES
-
United States Pharmacopoeia,
The United States
Pharmacopoeia Convention, Rockville, MD
-
Food Chemical Codex,
National Academy Press, Washington, DC
-
Aarti Naik,
Louk Pechtol, Russell 0. Potts, Richard H. Guy, “Mechanism
of oleic acid-induced skin penetration enhancement in vivo
in humans” Journal of Controlled Release 37 (1995) 299-306
-
Philip G. Green, Richard H. Guy, Jonathan Hadgraft, “In
vitro and in vivo enhancement of skin permeation with oleic
and lauric acids”, International Journal of
Pharmaceutics, 48 (1988) 103-111
-
Fumiyoshi Yamashita, Yasuo Koyama; Megumi Kitano; Yoshinobu
Takakura; Mitsuru Hashida “Analysis of in vivo skin
penetration enhancement by oleic acid based on a two-layer
diffusion model with polar and nonpolar routes in the
stratum corneum”, International Journal of Pharmaceutics
117 (1995) 173-179
-
M.A, Yamane, A.C. Williams, B.W. Barry, “Effects of terpenes
and oleic acid as skin penetration enhancers towards
5-fluorouracil as assessed with time; permeation,
partitioning and differential scanning calorimetry”,
International Journal of Pharrnaceutice 116 (1995) 237-251
-
Yacov Meshulam, Tamar Kadar, Ada Wengier, Shlomit Dachir,
and Aharon Levy, “Transdermal Penetration of Physostigmine:
Effects of Oleic Acid Enhancer”,Drug Development Research
28:510-515 (1993)
-
Green, Guy, Hadgraft, “In vitro and In vivo enhancement of
skin permeation with oleic and lauric acids”, Int'l J. of
Pharmaceutics, 48(1988)103-111
-
Tae-Wan Kim, Boem-Jin Lee, “Enhanced Bioavailabilty of
Aceclofenac Using Solid Dispersion:Bioequivalence Test of
Capsule and Tablet with Different Does in Human Volunteers”,
Proceedings of Controlled Release Society 29th
Annual Meeting
-
MacGregor, Embleton, Lacy, Perry, Solomon, Seager, Pouton,
“Influence of lipolysis on drug absorption from the
gastro-intestinal tract”, Adv. Drug Delivery Reviews 25
(1997) 33-46
-
Handbook of Pharmaceutical Excipients,
Second Edition, 1994, American Pharmaceutical Association
and the Royal Press, Royal Pharmaceutical Society of Great
Britain.
-
N.
Thorsgaard Pedersen, “Fat Digestion Test”, Digestion 37:
suppl. 1, pp. 25-34 (1987)
-
Bonte, Graham,
Moore, “Experimental Myocardial Imaging with 131I-Labeled
Oleic Acid”, Radiology 108: 195-196, July 1973

Click here to order a sample
Return to Featured Items
Archive |